CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 8-K Event Executive or director change · Other events
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-4 Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Other events
- 8-K/A Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- NT 10-Q Other NT 10-Q
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 91,396,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
Page 10 of 38 · 746 filings